← brief for 2026-08-20 · Slowing decline

Can MQ232 guide to novel options for treatment of ADPKD?

Paper D Peer reviewed Preclinical

Key takeaways

The study used MQ232 in mice with polycystic kidney disease (PKD). The drug slowed cyst growth but worked differently in males and females. It may offer new options for PKD treatment beyond tolvap_an.

Source

Paper · Kidney International · 2026-09-01
https://www.kidney-international.org/article/S0085-2538(26)00535-1/fulltext?rss=yes